Keystone Symposia
Home | My Account | Shopping Cart  0
  Advanced
     facebook  twitter
Meeting Details  Printer Version   Meeting Search   Contact Us

Fibrosis (J2)

Organizer(s): John Varga, Thomas A. Wynn and Shelia Violette
January 20 - 25, 2009
Keystone Resort  ·  Keystone, Colorado
Abstract Deadline: September 22, 2008
Late Abstract Deadline: October 22, 2008
Scholarship Deadline: September 22, 2008
Early Registration Deadline: November 20, 2008


Sponsored by Genzyme Corporation

The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Colorado School of Medicine designates this educational activity for a maximum of 28-35 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

To receive CME credits, mark the box on the registration form, and pay the additional $50.00.


Joint meeting: Allergy and Asthma (J1)
NOTE: Registration for meeting allows attendance at joint meeting (pending space availability).



This meeting took place in the 2009 season.

For a complete list of the meetings for the upcoming/current season,
see our meeting list, or search for a meeting.
Summary of Meeting
Fibrosis is a major cause of morbidity worldwide, can affect nearly all tissues, and is a dominant feature of diseases ranging from pulmonary fibrosis to glomerulosclerosis and cancer. Current treatments targeting the inflammatory cascade are ineffective in fibrosis. On-going research focuses on the role of innate immunity, and intrinsic mesenchymal cell alterations, plasticity, and progenitor cell differentiation in the pathogenesis. Experimental models, genetics and functional genomics have uncovered novel aspects of fibrosis, and innovative therapies are entering clinical trials. However, consensus on robust outcome measures or appropriate biomarkers for evaluating therapeutic effectiveness is lacking. This meeting brings together academic clinicians, researchers and pharmaceutical industry representatives from a variety of fields (1) to identify themes shared among the different fibrosing disorders, (2) to delineate promising novel molecular and cellular targets and treatment strategies, and (3) to discuss outcome measures and biomarkers for clinical trials. Opportunities for interdisciplinary interactions will be further enhanced by the concurrent meeting “Allergy and Asthma”, which will share a session with this meeting.

Tuesday, January 20
3:00 - 7:30 PM Registration Longs Peak Foyer
6:30 - 7:30 PM Refreshments Longs Peak Foyer
7:30 - 8:30 PM Keynote Address Longs Peak
Harry C. Dietz, Johns Hopkins University School of Medicine
TGF-beta, Microfibrils and Connective Tissue Homeostasis
Wednesday, January 21
7:00 - 8:00 AM Breakfast Quandary 1-3
8:00 - 11:15 AM Cellular Basis of Fibrosis: Focus on the Lung Longs Peak
* Moisés Selman, Instituto Nacional de Enfermedades Respiratorias
David A. Schwartz, National Jewish Medical and Research Center
Common Variants of MUC5AC and Pulmonary Fibrosis
Richard P. Phipps, University of Rochester
Fibroblast Heterogeneity –Impact of Fibroblast Diversity and Differentiation
Harold A. Chapman, University of California, San Francisco
Regulation of EMT and Pulmonary Fibrosis by Epithelial Integrins
Manuela Funke, Massachusetts General Hospital
Short Talk: Lysophosphatidic Acid Contributes to an Apoptosis Paradox in Lung Fibrosis
Boris Hinz, University of Toronto
Myofibroblasts and Mechanical Signal Transduction
Usamah S. Kayyali, Tufts Medical Center
Short Talk: MK2 Signaling in Fibroblast Biology and Pulmonary Fibrosis
9:20 - 9:40 AM Coffee Break Longs Peak Foyer
11:15 AM - On Own for Lunch
11:15 AM - 1:00 PM Poster Setup Quandary 1-3
1:00 - 10:00 PM Poster Viewing Quandary 1-3
2:30 - 4:30 PM Workshop 1: EMT, Plasticity and the Origin of Fibroblasts Longs Peak
* Richard H. Gomer, Rice University
* Robert Lafyatis, Boston University
Brandi Nicole Baird, Brown Foundation Institute of Molecular Medicine
Identification and Characterization of Prospectively Isolated Candidate Stem/Progenitor Cells in the Adult Mouse Lung
Marianne E. Fairclough, University of Birmingham
Diversity within Monocyte Derived Stromal Cells
Darrell Pilling, Texas A&M University
Th-1 Cytokines Inhibit, and Th-2 Cytokines Promote Fibrocyte Differentiation
Kirkwood A. Pritchard Jr., Medical College of Wisconsin
The Role of Matrix and Mesenchymal Transition in Fibrosis in Tight Skin Mice
Peter H. S. Sporn, Northwestern University Feinberg School of Medicine
Epithelial-Mesenchymal Transition in Normal Human Bronchial Epithelial Cells Triggered by TGF-beta1, Eosinophils and Cyclic Mechanical Strain
Shangxi Liu, University of Western Ontario
Loss of Beta 1 Integrin in Mouse Fibroblasts Results in Resistance to a bleo model of Skin Sclerodermav
Gregory deHart, FibroGen, Inc.
Regulation of Epithelial to Mesenchymal Transition by Connective Tissue Growth Factor
4:30 - 5:00 PM Coffee Available Longs Peak Foyer
5:00 - 7:00 PM Liver Fibrosis Longs Peak
* Thomas A. Wynn, National Institutes of Health
Anna Mae Diehl, Duke University Medical Center
The Cellular Biology and Clinical Spectrum of Liver Fibrosis
John P. Iredale, University of Edinburgh
Liver Fibrosis: A Dynamic Model of Inflammation and Repair
Margaret M. Mentink-Kane, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Short Talk: Accelerated Liver Fibrosis in the Combined Absence of Interleukin-13 Regulatory Molecules: IL-13 Receptor Alpha 2, IL-10 and IL-12
Scott L. Friedman, Mount Sinai School of Medicine
Genetic Determinants of Fibrosis Progression
7:00 - 8:00 PM Social Hour w/ Lite Bites Quandary 1-3
7:30 - 10:00 PM Poster Session 1 Quandary 1-3
Thursday, January 22
7:00 - 8:00 AM Breakfast Quandary 1-3
8:00 - 11:15 AM The Immunology and Cell Biology of Fibrosis Longs Peak
* John Varga, Northwestern University, Feinberg School of Medicine
Thomas A. Wynn, National Institutes of Health
Targets of IL-13 Signaling in Inflammation and Fibrosis
Erica Herzog, Yale University School of Medicine
Short Talk: Profibrotic Monocyte Subsets in Pulmonary Fibrosis
Rebecca G. Wells, University of Pennsylvania
Liver Fibrosis: The Intersection of Soluble and Mechanical Factors
Paul W. Noble, Duke University
Regulation and Lung Injury and Repair: Toll Like Receptors and Innate Immunity
Anna P. Lam, Northwestern University
Short Talk: Activated Canonical Wnt/beta-catenin Signaling Mediates Lung Fibroblast Migration and Proliferation
Victor J. Thannickal, University of Alabama at Birminham
Apoptosis and Fibroblast Survival in Fibrogenesis
9:20 - 9:40 AM Coffee Break Longs Peak Foyer
11:15 AM - On Own for Lunch
11:15 AM - 1:00 PM Poster Setup Quandary 1-3
1:00 - 10:00 PM Poster Viewing Quandary 1-3
2:30 - 4:30 PM Workshop 2: Model Systems for Studying Fibrosis Longs Peak
* Andrew M. Tager, Massachusetts General Hospital
* John Westwick†, Novartis Institutes for Biomedical Research
Shizhong Bu, Medical University of South Carolina
DhS1P has a Potent Anti-Fibrotic Effect in Scleroderma Fibroblasts via Modulation of PTEN Levels
Enrique Brandan, P. Universidad Católica de Chile
Induction of Fibrosis by Exercise on Dystrophic Muscles: Role of CTGF
Tomoko Hayashida, Feinberg School of Medicine, Northwestern University
Lack of beta1 Integrin Enhances TGF-beta Stimulated Type I Collagen Synthesis via Rac1 Mediated ERK Activity that Phosphorylates Smad Linker Region
Andreas Guenther, Pulmonary & Critical Care
Role of Defective Surfactant Processing and Transport in Hermansky-Pudlak-Syndrome Associated Interstitial Pneumonia (HPSIP) and Idiopathic Pulmonary Fibrosis (IPF)
Pura Muñoz Cánoves, Center for Genomic Regulation
Fibrin-Induced Inflammation Promotes Fibrosis in Muscular Dystrophy
Joe (Jia-hui) Wang, King's College London
Antisense Inhibition of Kirsten-Ras Expression Reduces Fibrosis in a Rat Model of Unilateral Ureteric Obstruction
4:30 - 5:00 PM Coffee Available Longs Peak Foyer
5:00 - 7:15 PM Renal Fibrosis Longs Peak
* Michael Zeisberg, Beth Israel Deaconess Medical Center and Harvard Medical School
Jeffrey B. Kopp, National Institutes of Health
Overview of Renal Fibrosis
Agnes Fogo, Vanderbilt University Medical Center
Animal Models and the Reversibility of Fibrosis
Jeremy S. Duffield, Harvard Medical School
Short Talk: Serum Amyloid P inhibits Renal Fibrosis through an Fc-gamma receptor dependent mechanism.
H. William Schnaper, Northwestern University
TGF-beta Signaling in Renal Fibrogenesis
Jeremy S. Duffield, Harvard Medical School
Short Talk: Genetic Fate tracing reveal the stromal pericyte not EMT Generates Myofibroblasts in the Obstructive Model of Kidney Fibrosis
7:00 - 8:00 PM Social Hour w/ Lite Bites Quandary 1-3
7:30 - 10:00 PM Poster Session 2 Quandary 1-3
Friday, January 23
7:00 - 8:00 AM Breakfast Quandary 1-3
8:00 - 11:15 AM Asthma, Allergy and Tissue Remodeling (Joint) Longs Peak / Grays Peak
* Cory M. Hogaboam, University of Michigan
Jack A. Elias, Yale School of Medicine
Insights from Transgenic Models of Lung Fibrosis
James J. Lee, Mayo Clinic Scottsdale
Eosinophils Orchestrate Allergic Pulmonary Responses: Who’s your Daddy Now T Cells!
John V. Fahy, University of California, San Francisco
Short Talk: Plasma Proteins Inhibit Protease-Dependent Degradation of Airway Mucus Plugs in Acute Asthma
Lauren E. Cohn, Yale University
Short Talk: IFN-gamma Modulates Allergic Airway Disease through Effects on the Airway Epithelium
Hajime Karasuyama, Tokyo Medical and Dental University
Short Talk: Basophils Resolve Inflammation through Alternate Activation of Macrophages
Jean Kim, Johns Hopkins University School of Medicine
Short Talk: Involvement of VEGF in Upper Airway Epithelial Cell Dysfunction in Chronic Rhinosinusitis with Nasal Polyposis Subjects
Stephen J. Galli, Stanford University
Mast Cells and Tissue Remodeling
9:20 - 9:40 AM Coffee Break Longs Peak Foyer
11:15 AM - On Own for Lunch
11:15 AM - 1:00 PM Poster Setup Quandary 1-3
1:00 - 10:00 PM Poster Viewing Quandary 1-3
4:30 - 5:00 PM Coffee Available Longs Peak Foyer
5:00 - 7:15 PM Environmental Cues and Cellular Responses Longs Peak
Rik Derynck, University of California, San Francisco
TGF-beta Signaling and Epithelial to Mesenchymal Transition
Florian Rieder, Lerner Research Institute
Short Talk: Endothelial-to-Mesenchymal Transition of Intestinal Mucosal Microvascular Cells: A Novel Mechanism of Intestinal Fibrosis
Andrew D. Luster, Massachusetts General Hospital
Inflammation and Fibrosis - Chemokines, LPA
Andrew M. Tager, Massachusetts General Hospital
Grease on the Fire: Chemokine- Lipid cooperation in Fibrosis
* Luisa A. DiPietro, University of Illinois at Chicago
Scar Formation in the Healing Wound
Keith C. Olsen, University of Rochester
Short Talk: Tissue Transglutaminase as a Novel Modulator of and Potential Therapeutic Target in Pulmonary Fibrosis
7:00 - 8:00 PM Social Hour w/ Lite Bites Quandary 1-3
7:30 - 10:00 PM Poster Session 3 Quandary 1-3
Saturday, January 24
7:00 - 8:00 AM Breakfast Quandary 1-3
8:00 - 11:15 AM Novel Therapeutic Targets and Biomarkers Longs Peak
* Michael Gilman, Stromedix, Inc.
Howard Y. Chang, Stanford University
Genomic Encoding of Fibroblast Positional Identities: Implications for Fibrosis
Roland M. duBois, National Jewish Health
Genetics of Diffuse Lung Fibrosis: Lessons Learned
Shelia M. Violette, Stromedix
Therapeutic Potential of a Function Blocking alphavbeta6 Antibody in Fibrosis and Oncology: Transition from Research to Clinic Development
Scott M. Lonning, Genzyme Corporation
Prospects and Challenges of TGFbeta Neutralization for the Treatment of Pathologic Fibrosis
Francesco Del Galdo, Thomas Jefferson University
Short Talk: Quantitative Assessment of Tissue Fibrosis in Skin Biopsies from Patients with Systemic Sclerosis Employing Confocal Laser Scanning Microscopy (CLSM). An Objective Outcome Measure for Clinical Trials
Kusum V. Pandit, University of Pittsburgh
Short Talk: MicroRNAs in Lung Fibrosis
9:20 - 9:40 AM Coffee Break Longs Peak Foyer
11:15 AM - On Own for Lunch
2:30 - 4:30 PM Workshop 3: Therapeutic Targets and Biomarkers Longs Peak
* Shelia M. Violette, Stromedix
April A. Cox, Array Biopharma
Preclinical Efficacy of a PDGFR inhibitor, ARRY-768, in a Rat Model of Gadolinium-Induced Fibrosis
Francesco Del Galdo, Thomas Jefferson University
A Pattern of Shared Alterations in the Secretome of Dermal Fibroblasts from Systemic Sclerosis and Nephrogenic Systemic Fibrosis: A Biomarker Signature for Fibrotic Diseases
Qihe Xu, King's College London School of Medicine
Discovery of Herbal Compounds with in vitro Anti-Fibrotic Activities
Jadranka Milosevic, Simmons Center for Interstitial Lung Disease
The Role of miR-154 microRNA Family in IPF
Jennifer L. Sargent, Dartmouth Medical School
Overlapping and Distinct Gene Targets of TGFbeta, IL13 and IL4 in Dermal Fibroblasts are Expressed in Distinct Molecular Subsets of Systemic Sclerosis
Timothy W. Schacker, University of Minnesota
Lymph Node Fibrosis Is A Significant Factor In HIV Pathogenesis And Limits Immune Reconstitution Despite Antiretroviral Therapy Suppression of Viral Replication
Oscar O. Braun, University of California San Diego
Cyclic AMP can Both Block and Reverse the Fibrotic Phenotype of Cardiac Fibroblasts
Guofei Zhou, Northwestern University
Elevated von Hippel-Lindau Protein Expression in Fibrotic Lungs and Its Role in Fibrogenesis
4:30 - 5:00 PM Coffee Available Longs Peak Foyer
5:00 - 7:00 PM Novel Therapies Longs Peak
* Scott M. Lonning, Genzyme Corporation
Bruce N. Cronstein, New York University School of Medicine
Venegeance is Mine. Adenosine, a Retaliatory Metabolite
Mark L. Lupher Jr., Promedior
Regulating Fibrosis with the Natural Innate Response Modifier, SAP
Claire L. Emson, KineMed, Inc.
Measurement of Collagen Synthesis by Heavy Water Labeling and its Application for Indentifying Anti-Fibrotic Therapies
Ruchi Bansal, University of Groningen
Short Talk: A Mimetic Peptide of Interferon gamma (IFNgamma) as a Novel Anti-Fibrotic Agent
7:00 - 8:00 PM Social Hour w/ Lite Bites Quandary 1-3
8:00 - 11:00 PM Entertainment Quandary 1-3
Sunday, January 25
Departure
*Session Chair   †Speaker invited, not yet responded.



© 2010 Keystone Symposia on Molecular and Cellular Biology. All Rights Reserved.
Terms of Use | Privacy Policy | Site Map

Keystone Symposia is a 501(c)(3) non-profit organization directed and supported by the scientific community.

Phone: +1 (800) 253-0685 or +1 (970) 262-1230
Fax: +1 (970) 262-1525
info@keystonesymposia.org